Cargando…

Combination of Drug Delivery Properties of PAMAM Dendrimers and Cytotoxicity of Platinum(IV) Complexes—A More Selective Anticancer Treatment?

Based on their drug delivery properties and activity against tumors, we combined PAMAM dendrimers with various platinum(IV) complexes in order to provide an improved approach of anticancer treatment. Platinum(IV) complexes were linked to terminal NH(2) moieties of PAMAM dendrimers of generation 2 (G...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lerchbammer-Kreith, Yvonne, Hejl, Michaela, Vician, Petra, Jakupec, Michael A., Berger, Walter, Galanski, Mathea S., Keppler, Bernhard K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221222/ https://www.ncbi.nlm.nih.gov/pubmed/37242758 http://dx.doi.org/10.3390/pharmaceutics15051515

Ejemplares similares

Platinum(IV)-Loaded Degraded Glycol Chitosan as Efficient Platinum(IV) Drug Delivery Platform
por: Lerchbammer-Kreith, Yvonne, et al.
Publicado: (2023)

Quaternary Ammonium Palmitoyl Glycol Chitosan (GCPQ) Loaded with Platinum-Based Anticancer Agents—A Novel Polymer Formulation for Anticancer Therapy
por: Lerchbammer-Kreith, Yvonne, et al.
Publicado: (2023)

Synthesis and characterization of novel bis(carboxylato)dichloridobis(ethylamine)platinum(IV) complexes with higher cytotoxicity than cisplatin
por: Varbanov, Hristo, et al.
Publicado: (2011)

Diamminetetrakis(carboxylato)platinum(IV) Complexes – Synthesis, Characterization, and Cytotoxicity
por: Hoffmeister, Björn R, et al.
Publicado: (2012)

NanoSIMS combined with fluorescence microscopy as a tool for subcellular imaging of isotopically labeled platinum-based anticancer drugs
por: Legin, Anton A., et al.
Publicado: (2014)

Theoretical Investigations and Density Functional Theory Based Quantitative Structure–Activity Relationships Model for Novel Cytotoxic Platinum(IV) Complexes
por: Varbanov, Hristo P., et al.
Publicado: (2012)

Behavior of platinum(iv) complexes in models of tumor hypoxia: cytotoxicity, compound distribution and accumulation†
por: Schreiber-Brynzak, Ekaterina, et al.
Publicado: (2016)

Multi-scale imaging of anticancer platinum(iv) compounds in murine tumor and kidney
por: Legin, A. A., et al.
Publicado: (2016)

The First Anticancer Tris(pyrazolyl)borate Molybdenum(IV) Complexes: Tested in Vitro and in Vivo—A Comparison of O,O‐, S,O‐, and N,N‐Chelate Effects
por: Berasaluce, Iker, et al.
Publicado: (2019)

The impact of whole human blood on the kinetic inertness of platinum(iv) prodrugs – an HPLC-ICP-MS study
por: Theiner, Sarah, et al.
Publicado: (2018)

Predicting cytotoxicity of PAMAM dendrimers using molecular descriptors
por: Jones, David E, et al.
Publicado: (2015)

A platinum(IV) prodrug strategy to overcome glutathione-based oxaliplatin resistance
por: Fronik, Philipp, et al.
Publicado: (2022)

Synthesis and in vitro Antitumor Potency of (Cyclohexane-1,2-Diamine)Platinum(II) Complexes with Aminotris(Methylenephosphonic Acid) as Bone-Seeking Ligand
por: Galanski, Markus, et al.
Publicado: (2005)

Tumor-targeted dual-action NSAID-platinum(iv) anticancer prodrugs
por: Kastner, Alexander, et al.
Publicado: (2023)

Osmium(IV) complexes with 1H- and 2H-indazoles: Tautomer identity versus spectroscopic properties and antiproliferative activity
por: Büchel, Gabriel E., et al.
Publicado: (2012)

Synthesis and Characterization of New Ethylenediamine Platinum(IV) Complexes Containing Lipophilic Carboxylate Ligands
por: Galanski, M., et al.
Publicado: (1995)

Anticancer Activity of Water-Soluble Olsalazine-PAMAM-Dendrimer-Salicylic Acid-Conjugates
por: Cortez-Maya, Sandra, et al.
Publicado: (2019)

Phosphorous-functionalized PAMAM dendrimers supported on mesoporous silica for Zr(iv) and Hf(iv) separation
por: Qin, Wei, et al.
Publicado: (2021)

Mechanism of Anticancer Action of Novel Imidazole Platinum(II) Complex Conjugated with G2 PAMAM-OH Dendrimer in Breast Cancer Cells
por: Czarnomysy, Robert, et al.
Publicado: (2021)

Selective cytotoxicity of PAMAM G5 core–PAMAM G2.5 shell tecto-dendrimers on melanoma cells
por: Schilrreff, Priscila, et al.
Publicado: (2012)

Highly Cytotoxic Molybdenocenes with Strong Metabolic Effects Inhibit Tumour Growth in Mice
por: Fuchs, Valentin, et al.
Publicado: (2022)

Chlorambucil Conjugated Ugi Dendrimers with PAMAM-NH(2) Core and Evaluation of Their Anticancer Activity
por: Seixas, Nalin, et al.
Publicado: (2019)

En Route to Osmium Analogues of KP1019: Synthesis, Structure, Spectroscopic Properties and Antiproliferative Activity of trans-[Os(IV)Cl(4)(Hazole)(2)]
por: Büchel, Gabriel E., et al.
Publicado: (2011)

Polyethylene glycolated PAMAM dendrimers-Efavirenz conjugates
por: Pyreddy, Suneela, et al.
Publicado: (2014)

Intrinsic Fluorescence of PAMAM Dendrimers—Quenching Studies
por: Konopka, Malgorzata, et al.
Publicado: (2018)

High Fluorescent Porphyrin-PAMAM-Fluorene Dendrimers
por: Garfias-Gonzalez, Karla I., et al.
Publicado: (2015)

Molecular Mechanisms of Antitumor Activity of PAMAM Dendrimer Conjugates with Anticancer Drugs and a Monoclonal Antibody
por: Marcinkowska, Monika, et al.
Publicado: (2019)

Acetylation of PAMAM dendrimers for cellular delivery of siRNA
por: Waite, Carolyn L, et al.
Publicado: (2009)

New Advances in General Biomedical Applications of PAMAM Dendrimers
por: de Araújo, Renan Vinicius, et al.
Publicado: (2018)

Hydrogel of Ketoconazole and PAMAM Dendrimers: Formulation and Antifungal Activity
por: Winnicka, Katarzyna, et al.
Publicado: (2012)

In Vitro Evaluation of Third Generation PAMAM Dendrimer Conjugates
por: Najlah, Mohammad, et al.
Publicado: (2017)

Twenty Years of Research on Cyclodextrin Conjugates with PAMAM Dendrimers
por: Arima, Hidetoshi
Publicado: (2021)

Organometallic 3-(1H-Benzimidazol-2-yl)-1H-pyrazolo[3,4-b]pyridines as Potential Anticancer Agents
por: Stepanenko, Iryna N., et al.
Publicado: (2011)

Biological activity of Pt(IV) prodrugs triggered by riboflavin-mediated bioorthogonal photocatalysis
por: Alonso-de Castro, Silvia, et al.
Publicado: (2018)

Trastuzumab-grafted PAMAM dendrimers for the selective delivery of anticancer drugs to HER2-positive breast cancer
por: Kulhari, Hitesh, et al.
Publicado: (2016)

Investigations on the Anticancer Potential of Benzothiazole-Based Metallacycles
por: Mokesch, Stephan, et al.
Publicado: (2020)

Bioconjugates of PAMAM dendrimers with trans-retinal, pyridoxal, and pyridoxal phosphate
por: Filipowicz, A, et al.
Publicado: (2012)

Diffusion NMR Study of Generation-Five PAMAM Dendrimer Materials
por: van Dongen, Mallory A., et al.
Publicado: (2014)

Cationic PAMAM Dendrimers as Pore-Blocking Binary Toxin Inhibitors
por: Förstner, Philip, et al.
Publicado: (2014)

Synthesis and Antimicrobial Properties of a Ciprofloxacin and PAMAM-dendrimer Conjugate
por: Svenningsen, Søren Wedel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g6sapml850t0hq2dl2jk5h7296